These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 17993041

  • 1. Evaluation of the safety of modafinil for treatment of excessive sleepiness.
    Roth T, Schwartz JR, Hirshkowitz M, Erman MK, Dayno JM, Arora S.
    J Clin Sleep Med; 2007 Oct 15; 3(6):595-602. PubMed ID: 17993041
    [Abstract] [Full Text] [Related]

  • 2. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE, Hirshkowitz M.
    Sleep; 2005 Apr 15; 28(4):464-71. PubMed ID: 16171291
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 5. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M, Black J.
    CNS Drugs; 2007 Mar 15; 21(5):407-16. PubMed ID: 17447828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 9. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE, Hull SG, Tiller J, Yang R, Harsh JR.
    J Clin Sleep Med; 2010 Oct 15; 6(5):458-66. PubMed ID: 20957846
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W.
    Chest; 2003 Dec 15; 124(6):2192-9. PubMed ID: 14665500
    [Abstract] [Full Text] [Related]

  • 13. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI, Black JE, Schwartz JR, Matheson JK.
    Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1675-81. PubMed ID: 11719309
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment.
    Weaver TE, Chasens ER, Arora S.
    J Clin Sleep Med; 2009 Dec 15; 5(6):499-505. PubMed ID: 20465014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.